Spaulding Clinical and FDA Study Contributing to Efforts to Address Opioid Crisis
WEST BEND, Wis. , January 25 /Businesswire/ - @SpauldingCRS and @US_FDA preliminary study results — part of the FDA’s proactive work to address the opioid crisis — evaluated two common psychotropic drug-opioid combinations compared to an opioid alone.